What are the Key Challenges in Manufacturing Cancer Therapies?
The manufacturing of cancer therapies faces several key challenges:
Precision and Consistency: Ensuring that each batch of therapy is consistent in quality and potency. Scalability: Scaling up production without compromising the quality of the therapy. Regulatory Compliance: Meeting the stringent guidelines set by regulatory bodies such as the FDA. Supply Chain Management: Managing the logistics of sourcing raw materials and delivering the final product to patients. Cost: The high costs associated with the sophisticated equipment and materials required for production.
